L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic Cells
Yoonki Heo(CHA Vaccine Institute (South Korea)), Eunyoung Chun(CHA Vaccine Institute (South Korea))
Cited by 11
Related Papers
Host microbiota constantly control maturation and function of microglia in the CNS
|Nature Neuroscience|2015|3.4k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
The human gut bacterial genotoxin colibactin alkylates DNA
|Science|2019|639